Summary
The single-dose pharmacokinetics of intravenously and orally administered tinidazole were studied in normal subjects and patients with severe chronic renal failure. The clearance of tinidazole was also measured in patients on regular haemodialysis.
After intravenous administration the mean elimination half-life of tinidazole was 17.1 ± 2.3 (SD) hours in the normal subjects and 16.9 ± 4.9 hours in patients with renal failure; the mean apparent volumes of distribution were 0.80 ± 0.09 L/kg and 0.69 ± 0.09 L/kg, respectively. Following oral administration the mean elimination half-life was 15.6 ± 1.6 hours in the normal subjects and 18.4 ± 3.5 hours in patients with renal failure; there were no statistically significant differences in these pharmacokinetic parameters. There was no accumulation of the major metabolite (hydroxymethyl tinidazole) in normal subjects or in patients with renal failure. Tinidazole clearance during haemodialysis was 71 ± 7.7 ml/min.
In the presence of renal failure no modification of tinidazole dosage would appear to be necessary. Tinidazole should be administered in full dosage following haemodialysis.
Similar content being viewed by others
References
Fiorino, S. and Ferraro, G.: A new drug, tinidazole in the treatment of vaginal trichomoniasis. Antibiotica 9: 58 (1971).
Flouvat, B.L.; Imbert, C; Dubois, D.M.; Temperville, B.P.; Roux, A.F.; Chevalier, G.C. and Humbert, G.: Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemo-dialysis. British Journal of Clinical Pharmacology 15: 735–741 (1983).
Hunt, P.S.; Davidson, A.J.L; Alden, J. and Cheng, S.: Bile and serum levels of tinidazole after a single oral dose. British Journal of Clinical Pharmacology 13: 233–234 (1982).
Kreeft, J.H.; Dufresne, L.R.; Ogilvie, R.I. and Turgeon, P.: Metronidazole kinetics in renal failure and on dialysis. Abstracts of the North American Metronidazole Symposium, Montreal (In press, 1983).
Nilsson-Ehle, I.; Ursing, B. and Nilsson-Ehle, P.: Liquid Chromatographie assay for metronidazole and tinidazole: Pharmacokinetics and metabolic studies in human subjects. Antimicrobial Agents and Chemotherapy 19: 754–760 (1981).
Sawyer, P.R.; Brogden, R.N.; Pinder, R.M.; Speight, T.M. and Avery, G.S.: Tinidarole: A review of its antiprotozoal activity and therapeutic efficacy. Drugs 11: 423–440 (1976).
Weidenbach, A. and Leix, H.: Treatment of trichomonal vaginitis with a single dose of tinidazole. Current Medical Research and Opinion 2: 147 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robson, R.A., Bailey, R.R. & Sharman, J.R. Tinidazole Pharmacokinetics in Severe Renal Failure. Clin Pharmacokinet 9, 88–94 (1984). https://doi.org/10.2165/00003088-198409010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198409010-00005